Cary, NC, United States of America

Brad Richard Henke


Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1999-2023

Loading Chart...
4 patents (USPTO):

Title: The Innovations of Brad Richard Henke

Introduction

Brad Richard Henke is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of four patents to his name, Henke's work focuses on novel compounds that have potential therapeutic applications.

Latest Patents

Henke's latest patents include the development of fused bicyclic alkylene linked imidodicarbonimidic diamides. These compounds are designed to be organic cation transporter selective compounds, which are believed to be useful in treating diseases and conditions associated with reduced activity of 5' adenosine monophosphate-activated protein kinase (AMPK). The specific compounds described in his patents include N-[2-(indol-3-yl)alkylene]-linked imidodicarbonimidic diamides and N-[2-(pyrrolopyridin-3-yl)alkylene]-linked imidodicarbonimidic diamides.

Career Highlights

Throughout his career, Henke has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and Novatarg, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Henke has collaborated with notable colleagues such as Timothy Mark Willson and Marcus Brackeen. These partnerships have likely enhanced his research and development efforts in the field of medicinal chemistry.

Conclusion

Brad Richard Henke's contributions to the field of medicinal chemistry through his innovative patents demonstrate his commitment to advancing therapeutic solutions. His work continues to have a significant impact on the development of new treatments for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…